violacein has been researched along with Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimi, SM; Wei, MQ; Xu, T | 1 |
Alshatwi, AA; Antonisamy, P; Subash-Babu, P | 1 |
2 other study(ies) available for violacein and Breast Cancer
Article | Year |
---|---|
Violacein anticancer activity is enhanced under hypoxia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Chromobacterium; Colonic Neoplasms; Escherichia coli; Female; Head and Neck Neoplasms; Humans; Indoles; Inhibitory Concentration 50; Lung Neoplasms; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Multigene Family; Neoplasms, Experimental; Salmonella typhimurium; Transformation, Bacterial; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |
Violacein induces apoptosis in human breast cancer cells through up regulation of BAX, p53 and down regulation of MDM2.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; In Situ Nick-End Labeling; Indoles; MCF-7 Cells; Proto-Oncogene Proteins c-mdm2; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2016 |